Possibilities of improvement of prognosis in patients with type 2 diabetes mellitus after coronary interventions

Kardiologiya

Volumn 51, Issue 7, 2011, Pages 17-22

  Lyamina, N P ^a   Karpova, E S ^a   Kotelnikova, E V ^a   Nosenko, A N ^a  

^a Saratov Research Institute of Cardiology   (Russian Federation)

Author keywords

Fenofibrate; Ischemic heart disease; Myocardial revascularization; Percutaneous coronary interventions; Type 2 diabetes mellitus

Indexed keywords

ANTILIPEMIC AGENT; FENOFIBRATE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DYSLIPIDEMIA; FEMALE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REOPERATION; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ADULT; AGED; ANGIOPLASTY, BALLOON, CORONARY; COMBINED MODALITY THERAPY; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FEMALE; FENOFIBRATE; HUMANS; HYPOLIPIDEMIC AGENTS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; PROGNOSIS; REOPERATION; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 80054091871     PISSN: 00229040     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. James R. W. Curopin. Lipidologia. 2001;12:425-431.
2. Lehto S., Ronnemaa T., Pyorala K., Laakso M. Dyslipidemia in Adults With Diabetes. Diabetologia 2000;43:148-155.
3. Mathew V., Gersh B. J., Williams BA. et al. Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation 2004;109:476-480.
4. Colivicchi F., Mettimanno M., Genovesi-Ebert A. et al. Differences between diabetic and non-diabetic hypertensive patients with first acute non-ST elevation myocardial infarction and predictors of in-hospital complications. J Cardiovasc Med 2008;9:267-272.
5. Kurbaan A., Bowker T., Ilsley C. et al. Difference in the mortality of the CABRI diabetic and nondiabetic populations and its relation to coronary artery disease and the revascularization mode. Am J Cardiol 2001;87:947-950.
6. Rozeuman Y., Sapoznikov D., Gotsman M. S. Restenosis and progression of coronary disease after balloon angioplasty in patients with diabetes mellitus. Clin Cardiol 2000;23:890-894.
7. + transport in diabetes mellitus. Diabetes 1990;39:850-854.
8. Ishii H., Umeda F., Hashimoto T., Nawata H. Increased intracellular calcium mobilization in platelets from patients with type 2 (non- insulindependent) diabetes mellitus. Diabetologia 1991;34:332-336.
9. Heart Protection Study Collaborativ Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomized placebo-controlled trial. Lancet 2002;360:8-22.